Korean J Nephrol.  2010 Jan;29(1):153-157.

A Case of Clopidogrel-induced Neutropenia in Chronic Renal Failure

Affiliations
  • 1Department of Internal Medicine, College of Medicine, CHA University, Seongnam, Korea. khj04@cha.ac.kr

Abstract

Clopidogrel, a thienopyridine derivative, is an anti-platelet agent that acts as an antagonist of the platelet adenosine diphosphate receptor and considered for essential prophylaxis for intracoronary stent thrombosis in the treatment of ischemic heart disease. Clopidogrel is considered as safe as aspirin but a few cases of severe hematologic adverse reactions associated with clopidogrel had been reported such as neutropenia, aplastic anemia, thrombocytopenic purpura, and thrombocytopenia. We report a rare case of neutropenia induced by clopidogrel in chronic renal failure in a patient who underwent percutaneous coronary intervention.

Keyword

Clopidogrel; Neutropenia; Chronic renal failure

MeSH Terms

Adenosine Diphosphate
Anemia, Aplastic
Aspirin
Blood Platelets
Humans
Kidney Failure, Chronic
Myocardial Ischemia
Neutropenia
Purpura, Thrombocytopenic
Pyridines
Stents
Thrombocytopenia
Thrombosis
Ticlopidine
Adenosine Diphosphate
Aspirin
Pyridines
Ticlopidine
Full Text Links
  • KJN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr